#Obstructive Sleep Apnea (OSA Pipeline) Market Analysis
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
1,644 Tumblr posts in 1 second.
Text
https://www.timessquarereporter.com/health/obstructive-sleep-apnea-osa-pipeline-market-is-estimated-to-witness-high-growth-owing-to-rising-prevalence-of-sleep-disorders
#Obstructive Sleep Apnea (OSA Pipeline) Market Trend#Obstructive Sleep Apnea (OSA Pipeline) Market Size#Obstructive Sleep Apnea (OSA Pipeline) Market Information#Obstructive Sleep Apnea (OSA Pipeline) Market Analysis#Obstructive Sleep Apnea (OSA Pipeline) Market Demand
0 notes
Text
Narcolepsy Treatment Market : Worldwide Industry Analysis and New Market Opportunities Explored By 2022 to 2028
Revenue from narcolepsy treatment. The market for narcolepsy treatment is anticipated to reach USD 6.67 billion by 2028, rising at a CAGR of 5.7% over the forecast period, from an estimated USD 4.77 billion in 2022. (2022-2028).
Future Market Insights (FMI), in its newly published market intelligence outlook, highlights substantial demand for narcolepsy treatment in North America. Narcolepsy treatment landscape in Europe, will witness significant revenue growth given the rising affinity toward adoption of prescription treatments and adherence to the same on a long term basis.
Due to the expansion of animal models for studying the neurological processes of the brain and any potential complexities, the neurobiology of sleep has made significant strides over the past few decades. The brain’s role in sleep is also included in this.
Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:
Strong distribution pipeline of the narcolepsy drugs.
Emerging global and local biopharmaceutical companies.
Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
Prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
Prevalence of sleep apnea is more severe in the developing countries due to the lack of skilled physicians
In term of key forward market strategies, the primary objective manufacturers in the narcolepsy treatment market is to expand their footprint in the various regional markets, in order to solidify their market position.
Get a Sample of this Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7641
Key Findings from the Regional and Competitive Landscape Analysis of Narcolepsy Treatment Market
Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
Apart from new product development—mostly arising from the presence of low cost generic versions of patented drugs, strategic partnerships and acquisitions with pave way for further business expansions.
Manufacturers in the global narcolepsy treatment are also focused towards introducing new research and development units in different geographic regions.
Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospital and retail, drug stores, and e-commerce. Sales through e-commerce distribution channel is expected to contribute a significant revenue share in the global narcolepsy treatment market.
FMI, has also noted an increasing focus on reformulation of well-known products and combinations, by manufacturers in North America in order to achieve higher sales and wide penetration.
Full Report @ https://www.futuremarketinsights.com/reports/narcolepsy-treatment-market
0 notes
Text
Obstructive Sleep Apnea Market Trends and Therapeutic Advancements !!
Covering the Therapeutic Advancements in Obstructive Sleep Apnea Treatment Scenario
Obstructive Sleep Apnea (OSA) is a common chronic sleep disorder, which is characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to a complete or partial obstruction of the airway, results of which are apneas, hypopneas, or sometimes both. Obstructive sleep apnea is a chronic and permanent condition, through proper therapy and medications the condition can be cured. Almost every system in the body is affected by Obstructive Sleep Apnea, resulting in an increased incidence of hypertension, stroke, altered immune system, and cardiovascular disease.
Obstructive Sleep Apnea is caused when the throat muscles relax during sleep, which causes the tissue in the back of the throat to collapse and block the upper airway. Daytime sleepiness is one of the most common symptoms of Obstructive Sleep Apnea. People affected with Obstructive Apnea also complain of memory problems, headaches in the morning, mood swings, or depression.
Obstructive Slee Apnea Epidemiology Classification
According to the analysis of DelveInsight, it is observed that the prevalence of Obstructive Sleep Apnea is higher in males than in females. The prevalence of OSA was observed to be approximately 24 million cases in the year 2021, out of which the United States was observed to have the higher prevalence among other countries.
The epidemiological segmentation of Obstructive Sleep Apnea can be done on teh basis of Gender-specific Obstructive Sleep Apnea prevalence, Diagnosed Obstructive Sleep Apnea Prevalence, and other factors. As per the analysis of DelveInsight the prevalence of Obstructive Sleep Apnea is more in the age group of 65 years and above.
Obstructive Sleep Apnea Market
In the past years, the prevalence of Obstructive Sleep Apnea has shown a rapid increase in the graph. The increasing prevalence has opened doors for many companies to develop therapies for the cure and many emerging therapies have cleared their clinical phases. The launch of the potential therapies in the market will help the patients to get a cure for the disease.
The increase in the prevalence of Obstructive Sleep Apnea is due to various factors like - increasing high blood pressure, type 2 diabetes, and congestive heart failure. The expected launch of the new therapies and mechanism of action is anticipated to fuel the Obstructive Sleep Apnea market in the upcoming years.
Emerging Drugs in Obstructive Sleep Apnea Pipeline
Over the years, a number of companies across the world are working hard toward developing novel treatment therapies with a tidy amount of success in the sleep disorder area. Key companies such as - Apnimed’s, RespireRx Pharmaceuticals, and many others are developing the drugs for Obstructive Sleep Apnea Treatment. There are a few other treatment therapies such as - AD109, Dronabinol, and others the therapies which are waiting for approval are either in the mid-phase or final phases of the clinical trials.
Way Ahead
The prevalence of Obstructive Sleep Apnea is increasing globally at a rapid pace. There is a substantial need for treatment therapies for the Obstructive Sleep Apnea market. Development of the novel drugs is considered to be an opportunity for the patients affected by the disease. There are people who are making the study material for OSA as well as the key players dedicated to working in the Obstructive Treatment landscape, who are among the factors that are responsible for the growth in the Obstructive Sleep Apnea treatment market.
To know more about our Competitive Services, Click here: Pharma Competitive Intelligence
Also, take a glance at the market insights reports by DelveInsight:
Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market
0 notes
Text
Pulmonary Arterial Hypertension (PAH) Market to Receive Overwhelming Hike in Revenues by 2020
In a recent report by Transparency Market Research (TMR), the vendor landscape for global pulmonary arterial hypertension (PAH) market is highly opportunistic. Since PAH has no permanent cure, the market is gaining popularity. A key factor to boost the growth of the PAH market is the availability of several treatment options for slowing down the spreading of the diseases, control symptoms, and enhancing the quality of life of patients.
Some of the leading players of the global market for PAH are United Therapeutics Corp., Novartis International AG, Pfizer Inc., Gilead Sciences Inc., and GlaxoSmithKline Plc. The key drugs available in the global market are PDE-5 inhibitors, ERAs, prostacyclin analogs, sGC stimulators, and Prostacyclin with ERAs contributing larger shares for revenue.
Request For Covid19 Impact Analysis on Pulmonary Arterial Hypertension (PAH) Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1181
As per the TMR report, the global pulmonary arterial hypertension market is estimated to exhibit an impressive CAGR of 17.90% within the forecast period of 2014 to 2020. The value is presumed to be at US$5.19 bn by the end of the forecast period. North America is anticipated to account for a king’s share during the forecast period followed by Europe. This is due to the high awareness about PAH treatments available that drives the growth of the market in both the regions.
Asia Pacific to Witness Stable Growth with Increase in Preference for Generic Drugs
The market is receiving a significant boost with the existence of promising pipelines and effective drugs approvals in present times. This is also acting as a primary factor in the growth and development of the pulmonary arterial hypertension market. The government is also taking active initiatives that are acting in favor of the PAH market growth.
According to a TMR, the license expiry of some blockbuster drugs are making way for generic drugs penetration. The increased sales of generic drugs adversely affect the overall revenue generation of the market since it is 70 to 80 per cent cheaper as compared to branded drugs. Cutting-edge therapies are developed for treating PAH. Therefore the future of pulmonary arterial hypertension market is presumed to be brighter in the years to come.
Request for Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1181
The market in Asia Pacific region is also presumed to be highly opportunistic in nature because of countries like China, Australia, Japan, New Zealand, and India, that has high growth rates. These emerging nations are estimated to be major global players in the future years.
Patent Expiry of PAH Drug Remedies Affecting Market Growth in Negative Light
Pulmonary arterial hypertension does not have a permanent cure. Medications may only help to decrease the speed by which the disease spreads into the body. In most developing countries, people are unaware of the treatment. This acts as a hindrance in the growth of the PAH market. Apart from that, high cost of such remedies and license expiry may also add as barrier in the growth and development of PAH in the market.
Request for Custom Research -
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1181
However, the global PAH market is anticipated to see growth in the coming years due to a number of factors like increase in the number of obese population, rise in the healthcare expenses, and ageing population. Growing population of women and their rising health complexities also gives way to PAH market for growth since PAH mostly result from high blood pressure in the lungs. This may further lead to other diseases like obstructive sleep apnea (OSA), and diastolic heart failure, hence creating vast opportunities for PAH market to grow. The key trends in this market are consumption of junk food items, continuous support provided by the government and increase in the number of cardiovascular diseases.
More Trending Reports by Transparency Market Research –
Clinical Laboratory Services Market –
https://www.globenewswire.com/news-release/2019/02/05/1710743/0/en/Clinical-Laboratory-Services-Market-to-Peg-a-Value-of-US-361-3-billion-by-2025-owing-to-Growing-Demand-for-Advanced-Healthcare-TMR.html
Amniotic Membrane Market –
https://www.biospace.com/article/amniotic-membrane-market-locally-available-amniotic-allografts-increasingly-meeting-needs-of-patients-with-joint-pain/
0 notes
Text
Sleep Apnea Devices Market to Incur Rapid Extension during 2019-2030
The latest market intelligence report on the Sleep Apnea Devices Market aims at exploring the unknown and coming up with solutions to the potential threats and challenges faced by the Market Industry Reports for the forecast period, 2019 to 2030.
Obstructive Sleep Apnea (OSA) is a common sleep related breathing disorder and the most effective treatment for patients is Positive Airway Pressure (PAP) sleep apnea devices. According to the journal published by International Journal of Research in Medical Sciences in 2017, in patients that use PAP the compliance rate is 30% – 80%, which is more as compared to compliance rate of other sleep apnea devices.
Get sample PDF @ https://www.marketindustryreports.com/pdf/77
Sleep Apnea Devices Market Prominent Players
The prominent players in the global sleep apnea devices market are ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Compumedics Limited, DeVilbiss Healthcare LLC, BMC Medical Co., Ltd, VYAIRE, Curative Medical, Invacare Corporation and Somnetics International, Inc
Sleep Apnea Devices Market by Region
Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing prevalence of sleep apnea and initiatives taken by the government & other private organizations to raise awareness about sleep disorders is expected to aid the growth of sleep apnea devices market in this region. Moreover, in India large number of undiagnosed people, expanding population and rising healthcare expenditure is anticipated to further boost the sleep apnea device market in the region.
Full report @ https://www.marketindustryreports.com/sleep-apnea-devices-market/77
Here are the questions we answer…
– Which emerging technologies are believed to impact the Sleep Anea Devices Market performance? – What are the key trends and dynamics? – Which regulations that will impact the industry? – Which segment will offer the most opportunity for growth between 2019 and 2030? – Where will most developments take place in the long term?
Get discount on report @ https://www.marketindustryreports.com/discount/77
Some Key Points for TOC
1. MARKET DYNAMICS ASSESMENT
1.1. Overview
1.2. Drivers
1.3. Barriers/Challenges
1.4. Opportunities
2. UNIQUE SELLING PROPOSITIONS (USPs)
2.1. Product Analysis (Snapshot)
2.2. Epidemiological Assessment
2.3. Pipeline Assessment
Buy report @ https://www.marketindustryreports.com/checkout/77
About Us
Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.
Contact Us-
502, Sai Radhe, Kennedy Road, Behind Hotel Sheraton Grand, Near Pune Station, Pune 411 001 Email: [email protected] Phone: +1 347 767 5477 ( US ) + 91 8956 767 535 ( IN ) Website: https://www.marketindustryreports.com/ Follow Us- LinkedIn | Twitter | Google+ | Facebook
from WordPress https://ift.tt/2jQOxXH via IFTTT
0 notes
Text
Narcolepsy Treatment Market: Competitive Dynamics & Global Outlook 2028
Revenue from narcolepsy treatment, globally is projected to stand at a valuation of US$ 3,818 Mn, registering an annual growth rate of 5.7 percent, from 2018-2028. Future Market Insights (FMI), in its newly published market intelligence outlook, highlights substantial demand for narcolepsy treatment in North America. Narcolepsy treatment landscape in Europe, will witness significant revenue growth given the rising affinity toward adoption of prescription treatments and adherence to the same on a long term basis.
Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:
Strong distribution pipeline of the narcolepsy drugs.
Emerging global and local biopharmaceutical companies.
Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
Prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
Prevalence of sleep apnea is more severe in the developing countries due to the lack of skilled physicians
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7641
In term of key forward market strategies, the primary objective manufacturers in the narcolepsy treatment market is to expand their footprint in the various regional markets, in order to solidify their market position.
Key Findings from the Regional and Competitive Landscape Analysis of Narcolepsy Treatment Market
Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
Apart from new product development—mostly arising from the presence of low cost generic versions of patented drugs, strategic partnerships and acquisitions with pave way for further business expansions.
Manufacturers in the global narcolepsy treatment are also focused towards introducing new research and development units in different geographic regions.
Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospital and retail, drug stores, and e-commerce. Sales through e-commerce distribution channel is expected to contribute a significant revenue share in the global narcolepsy treatment market.
FMI, has also noted an increasing focus on reformulation of well-known products and combinations, by manufacturers in North America in order to achieve higher sales and wide penetration.
Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-7641
There is a conscious shift from OTC medication to devices treating narcolepsy, driving significant revenue growth for the devices segment compared to drugs. Growing incidences of inappropriate medication and addiction, translating into severe side effects including headache, prolonged drowsiness, daytime memory and performance problems, allergic reactions, and death in some cases, is the key driving factor. These side effects are associated with OTC as well as prescription-based sleep aids. Growing demand to treat narcolepsy with BiPAP is expected to push this segment of devices—predicted to expand at the highest CAGR. Moreover, devices in portable and available-for-rent formats, will translate into higher adoption rates, throughout the forecast period. Portable Continuous positive airway pressure (CPAP) devices are lighter and smaller and can also be used as a home based unit, further reducing the dependency on OTC pills and prescription drugs.
While explaining the growth trajectory of narcolepsy treatment market, a senior analyst from the healthcare domain underscores growing healthcare expenditure and rising incidence cases of fracture fixation and orthopedic disorders as key factors contributing to the demand of narcolepsy treatment though 2028. “Regulatory impositions by various global authorities including the FDA and European Commission along with currency fluctuations, regulations and changing taxation policies are some high-impact factors pushing the global demand for narcolepsy treatment”, the analyst further explains.
Critical Market Restrainers
Although the narcolepsy market is expanding at a robust CAGR, long waiting time for sleep services, lack of awareness and delayed diagnosis, severe side effects of sleep aids medication, lack of proper documentation for the usage and licensing of sleeping pills, and improper equipment regulations are some critical factors projected to restrain the growth of narcolepsy treatment market.
0 notes
Text
Narcolepsy Treatment Market is projected to stand at a valuation of US$ 3,818 Mn By 2028
Revenue from narcolepsy treatment, globally is projected to stand at a valuation of US$ 3,818 Mn, registering an annual growth rate of 5.7 percent, from 2018-2028. Future Market Insights (FMI), in its newly published market intelligence outlook, highlights substantial demand for narcolepsy treatment in North America. Narcolepsy treatment landscape in Europe, will witness significant revenue growth given the rising affinity toward adoption of prescription treatments and adherence to the same on a long term basis.
Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:
Strong distribution pipeline of the narcolepsy drugs.
Emerging global and local biopharmaceutical companies.
Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
Prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
Prevalence of sleep apnea is more severe in the developing countries due to the lack of skilled physicians
In term of key forward market strategies, the primary objective manufacturers in the narcolepsy treatment market is to expand their footprint in the various regional markets, in order to solidify their market position.
Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7641
Key Findings from the Regional and Competitive Landscape Analysis of Narcolepsy Treatment Market
Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
Apart from new product development—mostly arising from the presence of low cost generic versions of patented drugs, strategic partnerships and acquisitions with pave way for further business expansions.
Manufacturers in the global narcolepsy treatment are also focused towards introducing new research and development units in different geographic regions.
Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospital and retail, drug stores, and e-commerce. Sales through e-commerce distribution channel is expected to contribute a significant revenue share in the global narcolepsy treatment market.
FMI, has also noted an increasing focus on reformulation of well-known products and combinations, by manufacturers in North America in order to achieve higher sales and wide penetration.
There is a conscious shift from OTC medication to devices treating narcolepsy, driving significant revenue growth for the devices segment compared to drugs. Growing incidences of inappropriate medication and addiction, translating into severe side effects including headache, prolonged drowsiness, daytime memory and performance problems, allergic reactions, and death in some cases, is the key driving factor. These side effects are associated with OTC as well as prescription-based sleep aids. Growing demand to treat narcolepsy with BiPAP is expected to push this segment of devices—predicted to expand at the highest CAGR. Moreover, devices in portable and available-for-rent formats, will translate into higher adoption rates, throughout the forecast period. Portable Continuous positive airway pressure (CPAP) devices are lighter and smaller and can also be used as a home based unit, further reducing the dependency on OTC pills and prescription drugs.
While explaining the growth trajectory of narcolepsy treatment market, a senior analyst from the healthcare domain underscores growing healthcare expenditure and rising incidence cases of fracture fixation and orthopedic disorders as key factors contributing to the demand of narcolepsy treatment though 2028. “Regulatory impositions by various global authorities including the FDA and European Commission along with currency fluctuations, regulations and changing taxation policies are some high-impact factors pushing the global demand for narcolepsy treatment”, the analyst further explains.
Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-7641
Critical Market Restrainers
Although the narcolepsy market is expanding at a robust CAGR, long waiting time for sleep services, lack of awareness and delayed diagnosis, severe side effects of sleep aids medication, lack of proper documentation for the usage and licensing of sleeping pills, and improper equipment regulations are some critical factors projected to restrain the growth of narcolepsy treatment market.
0 notes
Text
Jazz Pharmaceuticals to Highlight Breadth of Research in Narcolepsy and Excessive Sleepiness in Obstructive Sleep Apnea at SLEEP 2018
The following post e0a9e1e9e6412908cf53cee25f32209b62d23d03e119cd2df63e6855e8fc22eee0a9e1e9e6412908cf53cee25f32209b62d23d03e119cd2df63e6855e8fc22eepostlinke0a9e1e9e6412908cf53cee25f32209b62d23d03e119cd2df63e6855e8fc22eee0a9e1e9e6412908cf53cee25f32209b62d23d03e119cd2df63e6855e8fc22ee was first seen on Marc Le Francois' Sleep Blog
Jazz Pharmaceuticals plc will present 20 abstracts spanning the company’s sleep portfolio at SLEEP 2018.
“Jazz continues to invest in its pipeline and portfolio to deliver therapeutic options for the sleep community, and the breadth of data we are presenting at SLEEP is a testament to our substantial commitment to sleep medicine,” says Jed Black, MD, senior vice president, sleep and CNS medicine at Jazz Pharmaceuticals and adjunct professor, Stanford University Medical Center, Stanford Center for Sleep Sciences and Medicine, in a release. “We are particularly enthusiastic about our investigational medicine solriamfetol, which, if approved by the US Food and Drug Administration, will offer patients a new and robust treatment option, and the first new chemical entity for the treatment of excessive sleepiness in narcolepsy and OSA in the US in nearly 10 years.”
On March 2, 2018, Jazz announced that the US Food and Drug Administration (FDA) accepted for filing with standard review the company’s New Drug Application (NDA) seeking marketing approval for solriamfetol (JZP-110), an investigational medicine for the treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA).
Highlights at SLEEP will include:
Oral and poster presentations on results from an open-label, long-term safety and maintenance of efficacy study (TONES 5) of solriamfetol in the treatment of excessive sleepiness in patients with narcolepsy or OSA.
Oral and poster presentations examining the impact of solriamfetol on wakefulness throughout the day from the Phase 3 TONES 2 and TONES 3 studies.
Oral and poster presentations on post-hoc efficacy and safety analyses from the Phase 3 TONES 2 study for solriamfetol for excessive sleepiness in OSA, stratified by baseline cataplexy status.
Oral and poster presentations regarding the impact of narcolepsy and OSA on work productivity and quality of life.
Oral and poster presentations on the long-term safety and efficacy data from the Phase 2/3 study evaluating sodium oxybate in the treatment of pediatric patients with narcolepsy.
Poster on supporting safety for patients diagnosed with narcolepsy by restricting distribution of sodium oxybate to a central pharmacy using a central database and longitudinal monitoring.
A full list of Jazz-supported oral and poster presentations covering solriamfetol and sodium oxybate follows below:
Solriamfetol (JZP-110) Oral and Poster Presentations
A Long-Term Safety and Maintenance of Efficacy Study of Solriamfetol (JZP-110) in the Treatment of Excessive Sleepiness in Subjects with Narcolepsy or Obstructive Sleep Apnea
Solriamfetol (JZP-110) in the Treatment of Excessive Sleepiness in Narcoleptic Patients With and Without Cataplexy: Results From a Randomized, Phase 3, Clinical Trial
Solriamfetol (JZP-110) in the Treatment of Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea: Maintenance of Wakefulness Test Results Across the Day
Measures of Function, Work Productivity, and Quality of Life From a Phase 3 Study of Solriamfetol (JZP-110) in Patients with Narcolepsy
Impacts of Excessive Sleepiness Associated With Obstructive Sleep Apnea on Work Productivity
Using Multiple Anchor-based And Distribution-based Estimates To Determine The Minimal Important Difference (MID) For The FOSQ-10
US Healthcare Claims Analysis of Obstructive Sleep Apnea Comorbidities and Their Association with Stimulant Drug Use
Sodium oxybate / Narcolepsy-related Oral and Poster Presentations
Sodium Oxybate Treatment of Pediatric Narcolepsy: Effects on Weight, Height, and Pubertal Development
Sodium Oxybate Treatment of Narcolepsy in Pediatric Patients: Long-term Efficacy and Safety
Pharmacokinetics of Sodium Oxybate in Children and Adolescents with Narcolepsy with Cataplexy
Clinical and Patient Global Impression in a Phase 2/3 Study of Sodium Oxybate in Children and Adolescents with Narcolepsy with Cataplexy
Injuries, Motor Vehicle Accidents, and Near Misses in Narcolepsy: Results from the Nexus Narcolepsy Registry
Disease Burden in Pediatric Narcolepsy: a Claims-based Analysis of Healthcare Utilization and Costs, and Medical Comorbidity
Predictors of Time to Narcolepsy Diagnosis in Participants with Adult Onset of Symptoms: Results from the Nexus Narcolepsy Registry
US Prevalence of Narcolepsy and Other Sleep Disorders From 2013-2016: a Retrospective, Epidemiological Study Utilizing Nationwide Claims
Supporting Safety for Patients Diagnosed with Narcolepsy by Restricting Distribution of Sodium Oxybate to a Central Pharmacy Using a Central Database and Longitudinal Monitoring
The following investigator-sponsored trials focusing on sodium oxybate also will be presented:
Defining Disrupted Nighttime Sleep in Pediatric Narcolepsy
Role of diet in modulating the effects of sodium oxybate on weight gain in male Sprague-Dawley rats
Diagnostic Accuracy and Validity of the Swiss Narcolepsy Scale for the Diagnosis of Type 1 and Type 2 Narcolepsy Against Other Central Disorders of Hypersomnolence
The Bern Sleep-Wake Registry: Demographics And Clinical Characteristics of the First 6,831 Patients
from Sleep Review http://www.sleepreviewmag.com/2018/05/jazz-pharmaceuticals-highlight-breadth-research-narcolepsy-excessive-sleepiness-obstructive-sleep-apnea-sleep-2018/
from https://www.marclefrancois.net/2018/05/11/jazz-pharmaceuticals-to-highlight-breadth-of-research-in-narcolepsy-and-excessive-sleepiness-in-obstructive-sleep-apnea-at-sleep-2018/
0 notes
Text
Sleep Apnea Devices Market by Product Type, Devices and End Users | Analysis and Forecast by 2030
The latest report on sleep apnea devices the market industry takes a closer look at the value chain assessment for the forecast period, 2019 to 2030.
The Sleep Apnea Devices market report looks at the market division concerning the item and affiliation type, end-client applications, and market plans. The Sleep Apnea Devices market report gives the genuine progress portions and separate regions that strikingly influence the market improvement illustrated out data about the different states of the Sleep Apnea Devices advertise by and large. The Sleep Apnea Devices market report other than joins a surveyed impact of government’s standards and plans over the market. The Sleep Apnea Devices market report incorporates diverse decisive ways of thinking, for instance, SWOT examination to get the information regarding the evaluations spending vulnerabilities related to the flood of the market, which depends upon the present data.
Get demo PDF @ https://www.marketindustryreports.com/pdf/77
Obstructive Sleep Apnea (OSA) is a common sleep related breathing disorder and the most effective treatment for patients is Positive Airway Pressure (PAP) sleep apnea devices. According to the journal published by International Journal of Research in Medical Sciences in 2017, in patients that use PAP the compliance rate is 30% – 80%, which is more as compared to compliance rate of other sleep apnea devices. The most common reason for low patient compliance is the cost of the device. This factor is expected to hinder the growth of the global sleep apnea devices market during the forecast period.
Major Key Players in Sleep Apnea Market
The prominent players in the global sleep apnea devices market are ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Compumedics Limited, DeVilbiss Healthcare LLC, BMC Medical Co., Ltd, VYAIRE, Curative Medical, Invacare Corporation and Somnetics International, Inc
Get detail report @ https://www.marketindustryreports.com/sleep-apnea-devices-market/77
Sleep Apnea Devices Market by Region
Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing prevalence of sleep apnea and initiatives taken by the government & other private organizations to raise awareness about sleep disorders is expected to aid the growth of sleep apnea devices market in this region. Moreover, in India large number of undiagnosed people, expanding population and rising healthcare expenditure is anticipated to further boost the sleep apnea device market in the region.
Some Key Points for TOC
UNIQUE SELLING PROPOSITIONS (USPs)
Product Analysis (Snapshot)
Epidemiological Assessment
Pipeline Assessment
GLOBAL SLEEP APNEA DEVICES MARKET- ANALYSIS & FORECAST, BY PRODUCT
Therapeutic Devices
Adaptive Servo Ventilation (ASV) Devices
Positive airway pressure (PAP) Devices
Oral Appliances
Airway Clearance Systems
Oxygen Devices
Diagnostic Devices
Polysomnography (PSG) Devices
Oximeter
Actigraphy Devices
Other
Buy report @ https://www.marketindustryreports.com/checkout/77
About Us
Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.
We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of theart approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: [email protected]
Phone: + 91 9673535933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Facebook
from WordPress http://bit.ly/2xcymqK via IFTTT
0 notes
Text
Sleep Apnea Devices Market by Product Type, Devices and End Users | Analysis and Forecast by 2030
The latest report on sleep apnea devices the market industry takes a closer look at the value chain assessment for the forecast period, 2019 to 2030.
The Sleep Apnea Devices market report looks at the market division concerning the item and affiliation type, end-client applications, and market plans. The Sleep Apnea Devices market report gives the genuine progress portions and separate regions that strikingly influence the market improvement illustrated out data about the different states of the Sleep Apnea Devices advertise by and large. The Sleep Apnea Devices market report other than joins a surveyed impact of government’s standards and plans over the market. The Sleep Apnea Devices market report incorporates diverse decisive ways of thinking, for instance, SWOT examination to get the information regarding the evaluations spending vulnerabilities related to the flood of the market, which depends upon the present data.
Get demo PDF @ https://www.marketindustryreports.com/pdf/77
Obstructive Sleep Apnea (OSA) is a common sleep related breathing disorder and the most effective treatment for patients is Positive Airway Pressure (PAP) sleep apnea devices. According to the journal published by International Journal of Research in Medical Sciences in 2017, in patients that use PAP the compliance rate is 30% – 80%, which is more as compared to compliance rate of other sleep apnea devices. The most common reason for low patient compliance is the cost of the device. This factor is expected to hinder the growth of the global sleep apnea devices market during the forecast period.
Major Key Players in Sleep Apnea Market
The prominent players in the global sleep apnea devices market are ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Compumedics Limited, DeVilbiss Healthcare LLC, BMC Medical Co., Ltd, VYAIRE, Curative Medical, Invacare Corporation and Somnetics International, Inc
Get detail report @ https://www.marketindustryreports.com/77/sleep-apnea-devices-market
Sleep Apnea Devices Market by Region
Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing prevalence of sleep apnea and initiatives taken by the government & other private organizations to raise awareness about sleep disorders is expected to aid the growth of sleep apnea devices market in this region. Moreover, in India large number of undiagnosed people, expanding population and rising healthcare expenditure is anticipated to further boost the sleep apnea device market in the region.
Some Key Points for TOC
UNIQUE SELLING PROPOSITIONS (USPs)
Product Analysis (Snapshot)
Epidemiological Assessment
Pipeline Assessment
GLOBAL SLEEP APNEA DEVICES MARKET- ANALYSIS & FORECAST, BY PRODUCT
Therapeutic Devices
Adaptive Servo Ventilation (ASV) Devices
Positive airway pressure (PAP) Devices
Oral Appliances
Airway Clearance Systems
Oxygen Devices
Diagnostic Devices
Polysomnography (PSG) Devices
Oximeter
Actigraphy Devices
Other
Buy report @ https://www.marketindustryreports.com/checkout/77
About Us
Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.
We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of theart approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: [email protected]
Phone: + 91 9673535933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Facebook
\
from WordPress http://bit.ly/2wR0Qpz via IFTTT
0 notes
Text
Sleep Apnea Market Market Top Leading Countries, Companies, Consumption, Trends, Forces Analysis, Revenue, Challenges and Global Forecast 2019-2030
The latest report on sleep apnea devices the market industry takes a closer look at the value chain assessment for the forecast period, 2019 to 2030.
Market Industry Reports (MIR) has published a new report titled “Sleep Apnea Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global sleep apnea devices market is estimated to be over US$ 4 Billion in 2017. It is anticipated to grow at a substantial CAGR from 2019 to 2030.
Get sample PDF @ https://www.marketindustryreports.com/pdf/77
Sleep Apnea Devices Market Prominent Players
The prominent players in the global sleep apnea devices market are ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Compumedics Limited, DeVilbiss Healthcare LLC, BMC Medical Co., Ltd, VYAIRE, Curative Medical, Invacare Corporation and Somnetics International, Inc
Obstructive Sleep Apnea (OSA) is a common sleep related breathing disorder and the most effective treatment for patients is Positive Airway Pressure (PAP) sleep apnea devices. According to the journal published by International Journal of Research in Medical Sciences in 2017, in patients that use PAP the compliance rate is 30% – 80%, which is more as compared to compliance rate of other sleep apnea devices. The most common reason for low patient compliance is the cost of the device. This factor is expected to hinder the growth of the global sleep apnea devices market during the forecast period.
Sleep Apnea Devices Market by Region
Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing prevalence of sleep apnea and initiatives taken by the government & other private organizations to raise awareness about sleep disorders is expected to aid the growth of sleep apnea devices market in this region. Moreover, in India large number of undiagnosed people, expanding population and rising healthcare expenditure is anticipated to further boost the sleep apnea device market in the region.
Full report @ https://www.marketindustryreports.com/77/sleep-apnea-devices-market
Some Key Points for TOC
MARKET DYNAMICS ASSESMENT
Overview
Drivers
Barriers/Challenges
Opportunities
UNIQUE SELLING PROPOSITIONS (USPs)
Product Analysis (Snapshot)
Epidemiological Assessment
Pipeline Assessment
Buy report @ https://www.marketindustryreports.com/checkout/77
About Us
Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.
We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of theart approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: [email protected]
Phone: + 91 9673535933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Google+ | Facebook
from WordPress http://bit.ly/2K2eKhw via IFTTT
0 notes
Text
Sleep Apnea Devices Market by Product, Type, Application and End Users | Analysis and Forecast by 2030
The latest report on Sleep Apnea Devices the market industry takes a closer look at the value chain assessment for the forecast period, 2019 to 2030.
Market Industry Reports (MIR) has published a new report titled “Sleep Apnea Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global sleep apnea devices market is estimated to be over US$ 4 Billion in 2017. It is anticipated to grow at a substantial CAGR from 2019 to 2030.
Get sample PDF @ https://www.marketindustryreports.com/pdf/77
Sleep Apnea Devices Market Prominent Players
The prominent players in the global sleep apnea devices market are ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Compumedics Limited, DeVilbiss Healthcare LLC, BMC Medical Co., Ltd, VYAIRE, Curative Medical, Invacare Corporation and Somnetics International, Inc
Obstructive Sleep Apnea (OSA) is a common sleep related breathing disorder and the most effective treatment for patients is Positive Airway Pressure (PAP) sleep apnea devices. According to the journal published by International Journal of Research in Medical Sciences in 2017, in patients that use PAP the compliance rate is 30% - 80%, which is more as compared to compliance rate of other sleep apnea devices. The most common reason for low patient compliance is the cost of the device. This factor is expected to hinder the growth of the global sleep apnea devices market during the forecast period.
Sleep Apnea Devices Market by Region
Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing prevalence of sleep apnea and initiatives taken by the government & other private organizations to raise awareness about sleep disorders is expected to aid the growth of sleep apnea devices market in this region. Moreover, in India large number of undiagnosed people, expanding population and rising healthcare expenditure is anticipated to further boost the sleep apnea device market in the region.
Full report @ https://www.marketindustryreports.com/77/sleep-apnea-devices-market
Some Key Points for TOC
1. MARKET DYNAMICS ASSESMENT
1.1. Overview
1.2. Drivers
1.3. Barriers/Challenges
1.4. Opportunities
2. UNIQUE SELLING PROPOSITIONS (USPs)
2.1. Product Analysis (Snapshot)
2.2. Epidemiological Assessment
2.3. Pipeline Assessment
Buy report @ https://www.marketindustryreports.com/checkout/77
About Us
Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.
We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of theart approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: [email protected]
Phone: + 91 9673535933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Google+ | Facebook
0 notes
Text
Narcolepsy Treatment Market Analysis 2018 - 2028 By Product Type, By Distribution Channel, Analysis & Forecast
Revenue from narcolepsy treatment, globally is projected to stand at a valuation of US$ 3,818 Mn, registering an annual growth rate of 5.7 percent, from 2018-2028. Future Market Insights (FMI), in its newly published market intelligence outlook, highlights substantial demand for narcolepsy treatment in North America. Narcolepsy treatment landscape in Europe, will witness significant revenue growth given the rising affinity toward adoption of prescription treatments and adherence to the same on a long term basis.
Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:
Strong distribution pipeline of the narcolepsy drugs.
Emerging global and local biopharmaceutical companies.
Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
Prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
Prevalence of sleep apnea is more severe in the developing countries due to the lack of skilled physicians
In term of key forward market strategies, the primary objective manufacturers in the narcolepsy treatment market is to expand their footprint in the various regional markets, in order to solidify their market position.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7641
Key Findings from the Regional and Competitive Landscape Analysis of Narcolepsy Treatment Market
Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
Apart from new product development—mostly arising from the presence of low cost generic versions of patented drugs, strategic partnerships and acquisitions with pave way for further business expansions.
Manufacturers in the global narcolepsy treatment are also focused towards introducing new research and development units in different geographic regions.
Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospital and retail, drug stores, and e-commerce. Sales through e-commerce distribution channel is expected to contribute a significant revenue share in the global narcolepsy treatment market.
FMI, has also noted an increasing focus on reformulation of well-known products and combinations, by manufacturers in North America in order to achieve higher sales and wide penetration.
There is a conscious shift from OTC medication to devices treating narcolepsy, driving significant revenue growth for the devices segment compared to drugs. Growing incidences of inappropriate medication and addiction, translating into severe side effects including headache, prolonged drowsiness, daytime memory and performance problems, allergic reactions, and death in some cases, is the key driving factor. These side effects are associated with OTC as well as prescription-based sleep aids. Growing demand to treat narcolepsy with BiPAP is expected to push this segment of devices—predicted to expand at the highest CAGR. Moreover, devices in portable and available-for-rent formats, will translate into higher adoption rates, throughout the forecast period. Portable Continuous positive airway pressure (CPAP) devices are lighter and smaller and can also be used as a home based unit, further reducing the dependency on OTC pills and prescription drugs.
Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-7641
While explaining the growth trajectory of narcolepsy treatment market, a senior analyst from the healthcare domain underscores growing healthcare expenditure and rising incidence cases of fracture fixation and orthopedic disorders as key factors contributing to the demand of narcolepsy treatment though 2028. “Regulatory impositions by various global authorities including the FDA and European Commission along with currency fluctuations, regulations and changing taxation policies are some high-impact factors pushing the global demand for narcolepsy treatment”, the analyst further explains.
Critical Market Restrainers
Although the narcolepsy market is expanding at a robust CAGR, long waiting time for sleep services, lack of awareness and delayed diagnosis, severe side effects of sleep aids medication, lack of proper documentation for the usage and licensing of sleeping pills, and improper equipment regulations are some critical factors projected to restrain the growth of narcolepsy treatment market.
0 notes